Related Experiment Video

Updated: Sep 22, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

13.8K

Author Correction: Development of a novel anti-hepatitis B virus agent via Sp1

Michiyo Hayakawa1, Hideaki Umeyama2, Mitsuo Iwadate2

  • 1Department of Hepatology, Graduate School of Medicine, Osaka City University, Osaka, 545-8585, Japan.

Scientific Reports
|April 22, 2020
PubMed

Abstract:

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

More Related Videos

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
05:55

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System

Published on: December 21, 2019

7.1K
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.6K

Related Experiment Videos

Last Updated: Sep 22, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

13.8K
Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
05:55

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System

Published on: December 21, 2019

7.1K
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.6K

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...

Articles linked to this work by shared authors, journal, and citation graph.

Similar Long-Term Incidence of Hepatocellular Carcinoma in Chronic Hepatitis B Initiating Entecavir Versus Tenofovir Alafenamide: A REAL-B Study.

Journal of viral hepatitis·2026

Reduced Detection of Human Orphan Gene Transcripts in Disease Tissue Relative to Expression- and Detection- Matched Controls.

Biology·2026

Trends in the Proportion of Hepatitis C Virus Antibody-Positive Patients Who Could be Considered for Direct-Acting Antiviral Therapy Identified Through Preoperative Testing for Ophthalmic Surgery: A Nationwide Multicenter Real-World Cohort Study in Japan.

Hepatology research : the official journal of the Japan Society of Hepatology·2026

Antiviral therapies are associated with reduced mortality but under-utilized in patients with viral hepatocellular carcinoma: a multinational REAL-HCC study.

Hepatology international·2026

Tensor Decomposition-Based Unsupervised Feature Extraction Applied to Bioinformatics.

Methods in molecular biology (Clifton, N.J.)·2026

Novel 4D Tensor Decomposition-Based Approach Integrating Tri-Omics Profiling Data Can Identify Functionally Relevant Gene Clusters.

Biology·2026

Searching for separation between frequency-modulated calls of blue and fin whales.

Scientific reports·2026

Isolation and characterization of plant plasma membrane P-type H+-ATPase dimers.

Scientific reports·2026

Cold-induced vasomotion changes in healthy individuals and patients after median or ulnar nerve repair.

Scientific reports·2026

Integrated expression profiling reveals molecular crosstalk between CFTR, FASN, FRAP (mTOR), and BANK1 in hepatocellular carcinoma.

Scientific reports·2026

Low-cost IoT real-time environmental monitoring and one-hour LSTM forecasting for small-scale agricultural applications.

Scientific reports·2026

Emotion regulation strategy use and daily levels of affective arousal, affective valence and dissociation in a clinical sample.

Scientific reports·2026

Early hemoglobin trajectories and short-term mortality in ICU patients with traumatic brain injury: development in MIMIC-IV and external assessment in eICU-CRD.

Frontiers in neurology·2026

A programmable nanoplatform for inflammatory-state reprogramming in psoriasis treatment.

Journal of nanobiotechnology·2026

A novel inhalable tanshinone IIA lipid nanocrystal formulation for the enhanced treatment of idiopathic pulmonary fibrosis.

Journal of nanobiotechnology·2026

A large-scale expert-annotated 3D image dataset of dermal tissue macrophages.

Scientific data·2026

[The History of Evolution of Mechanical Thrombectomy Device Design and Introduction to Japanese Market].

No shinkei geka. Neurological surgery·2026

Late gadolinium enhancement dispersion mapping predicts major arrhythmic events in patients with prior myocardial infarction.

International journal of cardiology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us